NovoCure: Of The Initial Form 8k. This Amendment Provides A Description Of (i) The Compensation Of Ashley Cordova In Connection With Her Appointment As Chief Executive Officer Effective As Of January 1, 2025 And (ii) The Compensation Of Asaf Danziger In Connection With His Transition From Chief Executive Officer Of The Company To Senior Advisor To The Chief Executive Officer. At The Time Of The Filing Of The Initial Form 8k, The Compensation In Connection With Ms. Cordova’s Appointment And Danziger’s Transition Had Not Yet Been Determined. This Amendment Does Not Otherwise Modify Or Update Any Other Disclosures In The Initial Form 8k, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  NovoCure Limited
• Registration country
  Jersey
• Industry
  Medical Devices
• М/S&P/F
  *** / *** / ***